Market failure in the diffusion of clinician-developed innovations: The case of off-label drug discoveries
Medical doctors occasionally discover potentially valuable new off-label uses for drugs during their clinical practice. They apply these to help their own patients, but often have minimal incentives to invest in diffusing them further. Thus, the benefits that other clinicians might obtain are to som...
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
Oxford University Press
2017
|
| Online Access: | http://hdl.handle.net/1721.1/109473 https://orcid.org/0000-0002-7235-1032 |